Avacta Group Plc (AVCT) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Avacta Group Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.878 Good afternoon, ladies and gentlemen. Welcome to the Evactor Group PLC Interim Results 00:00:03.878 -- 00:00:07.644 Investor presentation. Throughout today's recording meeting, attendees will be in listen-only 00:00:07.644 -- 00:00:11.411 mode. Questions are encouraged. They can be submitted at any time just using the Q&A 00:00:11.411 -- 00:00:13.594 tab situated on the right-hand corner of your screen. 00:00:13.594 -- 00:00:16.940 Please simply type in your questions at any time and press send. 00:00:16.940 -- 00:00:20.766 Due to the significant attendance on today's call, the company will not be in a position 00:00:20.766 -- 00:00:22.889 to answer every question received in the meeting itself. 00:00:22.889 -- 00:00:26.155 However, the company can review all questions submitted today and will publish those 00:00:26.155 -- 00:00:28.599 responses where it's appropriate to do so. 00:00:28.599 -- 00:00:31.603 Before we begin, we'd like to submit the following poll, and I'm sure the company will 00:00:31.603 -- 00:00:35.329 be most grateful for your participation. I'd now like to hand over to the management 00:00:35.329 -- 00:00:38.872 team. Chris, Brian, good afternoon. 00:00:38.975 -- 00:00:44.023 Good afternoon, Mark. Thank you for having us and a good morning to our 00:00:44.023 -- 00:00:48.147 colleagues. across the pond in the States. 00:00:48.147 -- 00:00:53.673 My name is Christina Coughlin. I am the CEO of Avacta Therapeutics coming to you 00:00:53.673 -- 00:00:57.257 here from White City, London at our headquarters. 00:00:57.257 -- 00:01:02.522 And I am joined by my Chief Financial Officer, Brian Hahn. 00:01:02.522 -- 00:01:07.968 We look forward to delivering to you today our interim results for the period 00:01:07.968 -- 00...